| Bid Price | 43.05p | High Price | 43.40p |
|---|
| Ask Price | 43.45p | Low Price | 42.90p |
|---|
| Open Price | 43.00p | Spread | 0.92% |
|---|
| Prev Close | 42.80p | Volume | 246,420 |
|---|
Alliance Pharma PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Sep 23, 2024 | 42.85 | 44.00 | 42.50 | 42.80 | 711,510 |
| Sep 20, 2024 | 43.00 | 43.48 | 42.44 | 42.95 | 1,085,853 |
| Sep 19, 2024 | 41.70 | 42.95 | 41.40 | 42.90 | 3,224,961 |
| Sep 18, 2024 | 41.90 | 41.92 | 41.30 | 41.40 | 1,531,801 |
| Sep 17, 2024 | 43.20 | 44.09 | 41.80 | 41.90 | 1,379,937 |
Alliance Pharma PLC Information
| Name | Alliance Pharma PLC | Index | FTSE AIM 100 |
|---|
| ISIN | GB0031030819 | Epic | APH |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | AMSM |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 20,000 | Trading Status | Regular Trading |
|---|
| Shares in Issue | 540.57 m | Prev Close | 42.80p |
|---|
| PE Ratio | 285.714286 | Market Cap | £232.94 m |
|---|
| Div Yield | 0 | Div per Share | £0.00 |
|---|
| EPS | -£0.07 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.094138 | DPS Growth (%) | -0.3116 |
|---|
| Current Ratio | 2.565812 | Quick Ratio | 1.82704 |
|---|
Alliance Pharma PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 16/10/23 | EXR | Peter Butterfield | RES | 98,342 @ £0.00 | £0.00 |
| 16/10/23 | SELL | Peter Butterfield | RES | 74,343 @ £0.39 | £29,006.00 |
| 16/10/23 | EXR | Andrew Franklin | ED | 55,592 @ £0.00 | £0.00 |
| 16/10/23 | SELL | Andrew Franklin | ED | 42,053 @ £0.39 | £16,407.00 |
| 20/07/23 | BUY | Joanna Le Couilliard | RES | 40,957 @ £0.49 | £19,987.00 |
| 19/07/23 | BUY | Andrew Franklin | ED | 50,988 @ £0.49 | £25,010.00 |
| 19/07/23 | BUY | Richard Jones | NED | 53,000 @ £0.47 | £24,963.00 |
| 22/11/21 | SEXR | Peter Butterfield | RES | 269,417 @ £1.02 | £276,152.00 |
| 22/11/21 | EXR | Peter Butterfield | RES | 269,417 @ £0.48 | £127,973.00 |
| 22/04/21 | EXR | Peter Butterfield | RES | 205,000 @ £0.53 | £108,650.00 |
Alliance Pharma PLC News
